Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Hampe, CS; Lundgren, P; Daniels, TL; Hammerle, LP; Marcovina, SM; Lernmark, A
   A novel monoclonal antibody specific for the N-terminal end of GAD65
   JOURNAL OF NEUROIMMUNOLOGY
   
   C.S. Hampe et al., "A novel monoclonal antibody specific for the N-terminal end of GAD65", J NEUROIMM, 113(1), 2001, pp. 63-71
2. Iliescu, EA; Marcovina, SM; Morton, AR; Koschinsky, ML
   Apolipoprotein(a) phenotype, albumin clearance, and plasma levels of lipoprotein(a) in peritoneal dialysis
   NEPHRON
   
   E.A. Iliescu et al., "Apolipoprotein(a) phenotype, albumin clearance, and plasma levels of lipoprotein(a) in peritoneal dialysis", NEPHRON, 88(2), 2001, pp. 168-169
3. Becker, L; McLeod, RS; Marcovina, SM; Yao, ZM; Koschinsky, ML
   Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a)
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   L. Becker et al., "Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a)", J BIOL CHEM, 276(39), 2001, pp. 36155-36162
4. Friedlander, Y; Arbogast, P; Schwartz, SM; Marcovina, SM; Austin, MA; Rosendaal, FR; Reiner, AP; Psaty, BM; Siscovick, DS
   Family history as a risk factor for early onset myocardial infarction in young women
   ATHEROSCLEROSIS
   
   Y. Friedlander et al., "Family history as a risk factor for early onset myocardial infarction in young women", ATHEROSCLER, 156(1), 2001, pp. 201-207
5. Kim, H; Marcovina, SM; Edwards, KL; McKnight, B; Bradley, CM; McNeely, MJ; Psaty, BM; Motulsky, AG; Austin, MA
   Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemia
   CLINICAL GENETICS
   
   H. Kim et al., "Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemia", CLIN GENET, 60(3), 2001, pp. 188-197
6. Weisel, JW; Nagaswami, C; Woodhead, JL; Higazi, AAR; Cain, WJ; Marcovina, SM; Koschinsky, ML; Cines, DB; Bdeir, K
   The structure of lipoprotein(a) and ligand-induced conformational changes
   BIOCHEMISTRY
   
   J.W. Weisel et al., "The structure of lipoprotein(a) and ligand-induced conformational changes", BIOCHEM, 40(35), 2001, pp. 10424-10435
7. Mooser, V; Berger, MM; Tappy, L; Cayeux, C; Marcovina, SM; Darioli, R; Nicod, P; Chiolero, R
   Major reduction in plasma Lp(a) levels during sepsis and burns
   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
   
   V. Mooser et al., "Major reduction in plasma Lp(a) levels during sepsis and burns", ART THROM V, 20(4), 2000, pp. 1137-1142
8. Sirikci, O; Aytekin, V; Demiroglu, ICC; Demiroglu, C; Marcovina, SM
   Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty
   INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
   
   O. Sirikci et al., "Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty", INT J CL L, 30(2), 2000, pp. 93-99
9. Marcovina, SM; Landin-Olsson, M; Essen-Moller, A; Palmer, JP; Lernmark, A
   Evaluation of a novel radioimmunoassay using I-125-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies
   INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
   
   S.M. Marcovina et al., "Evaluation of a novel radioimmunoassay using I-125-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies", INT J CL L, 30(1), 2000, pp. 21-26
10. Sharp, DS; Burchfiel, CM; Rodriguez, BL; Sharrett, AR; Sorlie, PD; Marcovina, SM
    Apolipoprotein A-1 predicts coronary heart disease only at low concentrations of high-density lipoprotein cholesterol: an epidemiological study of Japanese-Americans
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
    
    D.S. Sharp et al., "Apolipoprotein A-1 predicts coronary heart disease only at low concentrations of high-density lipoprotein cholesterol: an epidemiological study of Japanese-Americans", INT J CL L, 30(1), 2000, pp. 39-48
11. Bray, GA; Culbert, IW; Champagne, CM; Dawson, L; Eberhardt, B; Greenway, FL; Guillory, FG; Hebert, AA; Jeffirs, ML; Kennedy, BM; Lovejoy, JC; Melancon, LE; Morris, LH; Reed, L; Perault, J; Ryan, DH; Sanford, DA; Smith, KG; Smith, LL; St Amant, JA; Tucker, E; Tulley, RT; Vicknair, PC; Williamson, D; Zachwieja, JJ; Tobian, JA; Matulik, MJ; Clarke, B; Collins, DA; Czech, KB; DeSandre, C; Ehrmann, DA; Geiger, G; Harding-Clay, B; Hilbrich, RM; McNabb, WL; Polonsky, KS; Semenske, AR; Stepp, KA; Watson, PG; Mendoza, JT; Smith, KA; Goldstein, BJ; Lark, C; Liberoni, R; Murphy, L; Pepe, C; Spandorfer, JM; Goldberg, RB; Rowe, P; Calles, J; Casanova, P; Donahue, RP; Florez, HJ; Giannella, A; McLymont, V; Mendez, J; O'Hara, P; Ojito, J; Prineas, R; Haffner, SM; Montez, MG; Miettinen, H; Mobley, CM; Mykkanen, LA; Rozek, MM; Hamman, RF; Nash, PV; Calonge, BN; Hill, JO; Hoyer, SR; Jortberg, BT; Miller-Stone, M; Regensteiner, JG; Seagle, H; Steinke, SC; Testaverde, L; Van-Dorsten, B; Horton, ES; Lawton, KE; Arky, RA; Bryant, M; Burke, JP; Caballero, E; Callaghan, KM; Ganda, OP; Franklin, T; Jackson, SD; Jacobsen, AM; Kula, LM; Kocal, M; Malloy, MA; Nicosia, M; Oldmixon, CF; Pan, J; Quitingon, M; Rubtchinsky, S; Seely, EW; Schweizer, D; Simonson, D; Smith, F; Solomon, CG; Warram, J; Kahn, SE; Montgomery, BK; Fujimoto, WY; Knopp, RH; Lipkin, EW; Marr, M; McCann, BS; Nguyen, TT; Palmer, JP; Schwartz, RS; Kitabchi, AE; Murphy, ME; Applegate, WB; Bryer-Ash, M; Crisler, A; Cunningham, G; Franklin, AW; Frieson, SL; Green, DL; Imseis, R; Kennedy, CL; Lambeth, HC; Lichtermann, LC; Oktaei, H; O'Toole, ML; Ricks, H; Rutledge, LMK; Sherman, AR; Smith, CM; Soberman, JE; Williams-Cleaves, BJ; Metzger, BE; Johnson, MK; Behrends, C; Cook, ML; Fitzgibbon, M; Heard, D; McPherson, D; Molitch, ME; Moore, M; Pitts, T; Roston, S; Schinleber, PA; Nathan, DM; McKitrick, C; Abbott, K; Anderson, E; Bissett, L; Cagliero, E; Crowell, S; Delahanty, L; Fritz, S; Levina, E; Michel, T; Norman, D; O'Keefe, J; Poulos, A; Ronan, L; Rosal, M; Salerno, M; Shagensky, C; Steiner, B; Turgeon, H; Young, A; Olefsky, JM; Carrion-Petersen, ML; Barrett-Connor, E; Beltran, M; Caenepeel-Mills, K; Edelman, SV; Ford, RO; Garcia, J; Henry, RR; Hill, M; Horne, J; Leos, D; Mudaliar, S; Pollard, A; Torio-Hurley, J; Pi-Sunyer, FX; Lee, JE; Allison, DB; Aronoff, NJ; Barreras, IM; Crandall, JP; Orlando, SJ; Parkes, K; Rooney, ES; Van Wye, GEH; Viscovich, KA; Marrero, DG; Kukman-Kelly, MS; Dotson, YF; Fineberg, SE; Guare, JC; Hadden, A; Ignaut, JM; Jackson, MA; Kirkman, MS; Porter, BD; Prince, MJ; Wheeler, ML; Ratner, RE; Youssef, G; Boner, A; Bronsord, M; Brown, E; Cheatham, WW; Cola, S; Comfort, A; Boggs, G; Evans, C; Levetan, C; Kellum, T; Nair, AK; Passaro, MD; Rubin, R; Shapiro, S; Saad, MF; Budgett, M; Jinagouda, SD; Aziz, A; Bernaba, B; Bodkin, SL; Ciobanu, V; Cosenza, C; Hagar, JE; Khan, A; Kumar, D; Khawaja, Q; Lui, G; Marston, AR; Mehta, V; Sharma, AR; Szamos, K; Vargas, A; Vargas, B; Zambrana, N; Dagogo-Jack, S; Santiago, AS; Brendle, JS; Fisher, EB; Gherardini, DC; Heins, JM; Marsala, JM; Raspberry, CC; Santiago, JV; Saudek, CD; Bradley, VL; Brancati, FL; Cappelli, S; Charleston, JB; Rubin, RR; Stewart, KJ; Sullivan, E; Schade, DS; Adams, KS; Atler, LF; Bowling, DA; Boyle, PJ; Burge, MR; Butler, L; Canady, JL; Chai, L; Guillen, M; Gutierrez, M; Hornbeck, D; Johannes, C; Katz, P; King, C; McCalman, R; Montoya, DA; Rassam, A; Senter, W; Shamoon, H; Brown, JO; Adames, J; Blanco, E; Cox, L; Duffy, H; Engel, S; Friedler, A; Harroun, T; Howard-Century, CJ; Kloiber, S; Longchamp, N; Pompi, D; Walker, EA; Wylie-Rosett, J; Zonszein, J; Wing, RR; Kramer, MK; Barr, S; Clifford, L; Culyba, R; Frazier, M; Gilligan, R; Harris, L; Harrier, S; Henderson, W; Jeffries, S; Koenning, G; Maholic, K; Mullen, M; Noel, A; Orchard, TJ; Otto, A; Smith, M; Stapinski, V; Viteri, J; Wilson, T; Williams, KV; Zgibor, J; Arakaki, RF; Latimer, RW; Baker-Ladao, NK; Beddow, RM; Dias, LM; Dupont, DA; Fukuhara, LL; Mau, MK; Odom, SK; Perry, RU; Tokunaga, JS; Knowler, WC; Cooeyate, NJ; Hoskin, MA; Percy, CA; Acton, KJ; Andre, VL; Antone, S; Baptisto, NM; Barber, R; Bennett, PH; Benson, MB; Bird, EC; Broussard, BA; Chavez, M; Dacawyma, TS; Duncan, R; Ghahate, JM; Glass, M; Gohdes, D; Grant, G; Hanson, RL; Horse, E; Hughte, G; Ingraham, LE; Jackson, MC; Jay, PA; Kaskalla, RS; Kessler, D; Kobus, KM; Morgan, T; Nashboo, Y; Poirier, S; Reidy, M; Ridpath, S; Roumain, J; Rowse, DH; Roy, RJ; Sangster, S; Sewemaenewa, J; Wilson, C; Yazzie, M; Fowler, S; Bain, R; Bamdad, J; Brenneman, T; Callaghan, J; Edelstein, SL; Grimes, KL; Jones, S; Jones, TL; Lachin, JM; Mucik, P; Orlosky, R; Stimpson, CE; Suiter, C; Temprosa, E; Van Aerden, C; Eastman, R; Garfield, S; Andres, R; Engelgau, MM; Narayan, KMV; Williamson, DF; Herman, WH; Marcovina, SM; Aldrich, A; Chandler, WL; Rautaharju, PM; Alexander, T; Pemberton, NT; Prineas, R; Rautaharju, FSR; Zhang, Z; Mayer-Davis, EJ; Martin, M; O'Leary, DH; Funk, LRC; O'Leary, KA; Polak, JF; Stamm, ER; Scherzinger, AL; Wing, RR; Gillis, BP; Kriska, AM; Huffmyer, C; Venditti, EM; Kaplan, RM; David, KM; Sieber, WJ
    The Diabetes Prevention Program - Baseline characteristics of the randomized cohort
    DIABETES CARE
    
    G.A. Bray et al., "The Diabetes Prevention Program - Baseline characteristics of the randomized cohort", DIABET CARE, 23(11), 2000, pp. 1619-1629
12. Hoeldtke, RD; Bryner, KD; Hobbs, GR; Horvath, GG; Riggs, JE; Christie, I; Ganser, G; Marcovina, SM; Lernmark, A
    Antibodies to glutamic acid decarboxylase and peripheral nerve function intype 1 diabetes
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    R.D. Hoeldtke et al., "Antibodies to glutamic acid decarboxylase and peripheral nerve function intype 1 diabetes", J CLIN END, 85(9), 2000, pp. 3297-3308
13. Cheesman, EJ; Sharp, RJ; Zlot, CH; Liu, CYY; Taylor, S; Marcovina, SM; Young, SG; McCormick, SPA
    An analysis of the interaction between mouse apolipoprotein B100 and apolipoprotein(a)
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    E.J. Cheesman et al., "An analysis of the interaction between mouse apolipoprotein B100 and apolipoprotein(a)", J BIOL CHEM, 275(36), 2000, pp. 28195-28200
14. Demacker, PNM; Veerkamp, MJ; Bredie, SJH; Marcovina, SM; de Graaf, J; Stalenhoef, AFH
    Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia
    ATHEROSCLEROSIS
    
    P.N.M. Demacker et al., "Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia", ATHEROSCLER, 153(2), 2000, pp. 483-490
15. Marcovina, SM; Albers, JJ; Scanu, AM; Kennedy, H; Giaculli, F; Berg, K; Couderc, R; Dati, F; Rifai, N; Sakurabayashi, I; Tate, JR; Steinmetz, A
    Use of a reference material proposed by the international federation of clinical chemistry and laboratory medicine to evaluate analytical methods forthe determination of plasma lipoprotein(a)
    CLINICAL CHEMISTRY
    
    S.M. Marcovina et al., "Use of a reference material proposed by the international federation of clinical chemistry and laboratory medicine to evaluate analytical methods forthe determination of plasma lipoprotein(a)", CLIN CHEM, 46(12), 2000, pp. 1956-1967
16. Kardaun, JWPF; White, L; Resnick, HE; Petrovitch, H; Marcovina, SM; Saunders, AM; Foley, DJ; Havlik, RJ
    Genotypes and phenotypes for apolipoprotein E and Alzheimer disease in theHonolulu-Asia Aging Study
    CLINICAL CHEMISTRY
    
    J.W.P.F. Kardaun et al., "Genotypes and phenotypes for apolipoprotein E and Alzheimer disease in theHonolulu-Asia Aging Study", CLIN CHEM, 46(10), 2000, pp. 1548-1554
17. Marcovina, SM
    High antifibrinolytic activity of lipoprotein(a) containing small apolipoprotein(a) isoforms - Response
    CIRCULATION
    
    S.M. Marcovina, "High antifibrinolytic activity of lipoprotein(a) containing small apolipoprotein(a) isoforms - Response", CIRCULATION, 102(25), 2000, pp. E184-E185
18. Mooser, V; Helbecque, N; Miklossy, J; Marcovina, SM; Nicod, P; Amouyel, P
    Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease
    ANNALS OF INTERNAL MEDICINE
    
    V. Mooser et al., "Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease", ANN INT MED, 132(7), 2000, pp. 533-537
19. Tate, JR; Berg, K; Couderc, R; Dati, F; Kostner, GM; Marcovina, SM; Rifai, N; Sakurabayashi, I; Steinmetz, A
    International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) standardization project for the measurement of lipoprotein(a). Phase 2:Selection and properties of a proposed secondary reference material for lipoprotein(a).
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    J.R. Tate et al., "International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) standardization project for the measurement of lipoprotein(a). Phase 2:Selection and properties of a proposed secondary reference material for lipoprotein(a).", CLIN CH L M, 37(10), 1999, pp. 949-958
20. Marcovina, SM; Kennedy, H; Bon, GB; Cazzolato, G; Galli, C; Casiglia, E; Puato, M; Pauletto, P
    Fish intake, independent of apo(a) size, accounts for lower plasma lipoprotein(a) levels in Bantu fishermen of Tanzania - The Lugalawa study
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    S.M. Marcovina et al., "Fish intake, independent of apo(a) size, accounts for lower plasma lipoprotein(a) levels in Bantu fishermen of Tanzania - The Lugalawa study", ART THROM V, 19(5), 1999, pp. 1250-1256
21. Mooser, V; Tinguely, F; Fontana, P; Lenain, V; Vaglio, M; Ruchat, P; von Segesser, LK; Marcovina, SM; Markert, M; Darioli, R; Nicod, P
    Effect of cardiopulmonary bypass and heparin on plasma levels of Lp(a) andapo(a) fragments
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    V. Mooser et al., "Effect of cardiopulmonary bypass and heparin on plasma levels of Lp(a) andapo(a) fragments", ART THROM V, 19(4), 1999, pp. 1060-1065
22. Fontana, P; Mooser, V; Bovet, P; Shamlaye, C; Burnand, B; Lenain, V; Marcovina, SM; Riesen, W; Darioli, R
    Dose-dependent inverse relationship between alcohol consumption and serum Lp(a) levels in black African males
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    P. Fontana et al., "Dose-dependent inverse relationship between alcohol consumption and serum Lp(a) levels in black African males", ART THROM V, 19(4), 1999, pp. 1075-1082
23. Tao, RX; Acquati, F; Marcovina, SM; Hobbs, HH
    Human growth hormone increases Apo(a) expression in transgenic mice
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    R.X. Tao et al., "Human growth hormone increases Apo(a) expression in transgenic mice", ART THROM V, 19(10), 1999, pp. 2439-2447
24. Testa, R; Marcovina, SM
    The rate of plasmin formation after in vitro clotting is inversely relatedto lipoprotein(a) plasma levels
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
    
    R. Testa e S.M. Marcovina, "The rate of plasmin formation after in vitro clotting is inversely relatedto lipoprotein(a) plasma levels", INT J CL L, 29(3), 1999, pp. 128-132
25. Legault, C; Stefanick, ML; Miller, VT; Marcovina, SM; Schrott, HG
    Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: The Postmenopausal Estrogen/Progestins Interventions (PEPI) trial
    JOURNAL OF CLINICAL EPIDEMIOLOGY
    
    C. Legault et al., "Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: The Postmenopausal Estrogen/Progestins Interventions (PEPI) trial", J CLIN EPID, 52(12), 1999, pp. 1187-1195
26. Sibley, SD; Hokanson, JE; Steffes, MW; Purnell, JQ; Marcovina, SM; Cleary, PA; Brunzell, JD
    Increased small, dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes (vol 22, pg 1165, 1999)
    DIABETES CARE
    
    S.D. Sibley et al., "Increased small, dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes (vol 22, pg 1165, 1999)", DIABET CARE, 22(9), 1999, pp. 1601-1601
27. Sibley, SD; Hokanson, JE; Steffes, MW; Purnell, JQ; Marcovina, SM; Cleary, PA; Brunzell, JD
    Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes
    DIABETES CARE
    
    S.D. Sibley et al., "Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes", DIABET CARE, 22(7), 1999, pp. 1165-1170
28. Bray, GA; Culbert, IW; Champagne, CM; Dawson, L; Eberhardt, B; Greenway, FL; Guillory, FG; Hebert, AA; Jeffirs, ML; Kennedy, BM; Lovejoy, JC; Morris, LH; Melancon, LE; Reed, L; Perault, J; Ryan, DH; Sanford, DA; Smith, KG; Smith, LL; St Amant, JA; Tulley, RT; Vicknair, PC; Williamson, D; Zachwieja, JJ; Polonsky, KS; Matulik, MJ; Clarke, B; DeSandre, C; Ehrmann, DA; Hilbrich, RM; McNabb, WL; Morrone, D; Semenske, AR; Stepp, KA; Tobian, JA; Watson, PG; Caro, JF; Goldstein, BJ; Graziani, CM; Kunkel, EJ; Laine, CA; Louis, DZ; Smith, KA; Spandirfer, J; Yuen, EJ; Goldberg, RB; Rowe, P; Calles, J; Donahue, RP; Florez, HJ; Giannella, A; O'Hara, P; Prineas, R; Haffner, SM; Montez, MG; Miettinen, H; Mobley, CM; Mykkanen, LA; Hamman, RF; Nash, PV; Calonge, BN; Hill, JO; Jortberg, BT; Regensteiner, JG; Reusch, J; Schiltz, CM; Seagle, H; VanDorsten, B; Horton, ES; Lawton, KE; Arky, RA; Bryant, M; Burke, JP; Caballero, E; Callaphan, KM; Ganda, OP; Franklin, T; Jackson, SD; Jacobsen, AM; Kula, LM; Kocal, M; Malloy, MA; Nicosia, M; Oldmixon, CF; Pan, J; Quitingon, M; Rubtchinsky, S; Seely, EW; Schweizer, D; Simonson, D; Smith, F; Solomon, CG; Warram, J; Kahn, SE; Montgomery, BK; Berger, M; Boyko, EJ; Fujimoto, WY; Greenbaum, CJ; Knopp, RH; McCann, BS; Lipkin, EW; Nguyen, TT; Palmer, JP; Schwartz, RS; Talbot-Lawson, C; Wan, D; Kitabchi, AE; Murphy, ME; Applegate, WB; Bryer-Ash, M; Frieson, SL; Imseis, R; Kennedy, CL; Lambeth, HC; Lichtermann, LC; Oktaei, H; O'Toole, ML; Rutledge, LMK; Sherman, AR; Smith, CM; Soberman, JE; Williams-Cleaves, BJ; Metzger, BE; Johnson, MK; Fitzgibbon, M; Heard, D; Johnson, CKH; McPherson, D; Molitch, ME; Moore, M; Pitts, T; Schinleber, PA; Nathan, DM; McKitrick, C; Abbott, K; Anderson, E; Cagliero, E; Cohen, M; Crowell, S; Delahanty, L; Levina, E; Michel, T; O'Keefe, J; Poulos, A; Ronan, L; Rosal, M; Salerno, M; Shagensky, C; Steiner, B; Young, A; Olefsky, JM; Carrion-Petersen, ML; Barrett-Connor, E; Beltran, M; Caenepeel, K; Edelman, SV; Ford, RO; Garcia, J; Henry, RR; Hill, M; Horne, J; Leos, D; Mudaliar, S; Pollard, A; Torio, J; Pi-Sunyer, FX; Lee, JE; Allison, DB; Aronoff, NJ; Barreras, IM; Crandall, JP; Foo, ST; Orlando, SJ; Parkes, K; Rooney, ES; Van Wye, GEH; Viscovich, KA; Prince, MJ; Kukman, SM; Dotson, YF; Fineberg, ES; Guare, JC; Ignaut, JM; Jackson, MA; Kirkman, MS; Marrero, DG; Porter, DB; Rowland, ND; Wheeler, ML; Ratner, RE; Youssef, G; Bronsord, M; Cheatham, WW; Boggs, G; Evans, C; Levatan, C; Kellum, T; Nair, AK; Passaro, MD; Saad, MF; Khan, A; Aziz, A; Bernaba, B; Budgett, MD; Cosenza, C; Hagar, JE; Isagholian, K; Jinagouda, SD; Kamdar, VV; Kumar, D; Khawaja, Q; Kelada, BL; Lui, G; Marston, AR; Mehta, V; Sharma, AR; Szamos, K; Vargas, A; Vargas, B; Zambrana, N; Dagogo-Jack, S; Santiago, AE; Brendle, JS; Fisher, EB; Gherardini, DC; Heins, JM; Marsala, JM; Raspberry, CC; Santiago, JV; Stephan, CL; Saudek, CD; Bradley, VL; Brancati, FL; Cappelli, S; Charleston, JB; Rubin, RR; Stewart, KJ; Sullivan, E; Schade, DS; Adams, KS; Atler, LF; Bowling, DA; Boyle, PJ; Burge, MR; Canady, JL; Chai, L; Dorin, RI; Facio, E; Guillen, M; Gutierrez, M; Johannes, C; Katz, P; King, C; McCalman, R; Rassam, A; Senter, W; Waters, D; Shamoon, H; Brown, JO; Cox, L; Duffy, H; Engel, S; Friedler, A; Howard-Century, CJ; Longchamp, N; Pompi, D; Walker, EA; Wylie-Rosett, J; Zonszein, J; Wing, RR; Kramer, MK; Barr, S; Clifford, L; Culyba, R; Frazier, M; Harris, L; Harrier, S; Henderson, W; Jeffries, S; Koenning, G; Maholic, K; Mullen, M; Noel, A; Orchard, T; Smith, CF; Smith, M; Viteri, J; Wilson, T; Williams, KV; Zgibor, J; Arakaki, RF; Latimer, RW; Baker-Ladao, NK; Beddow, RM; Dias, LM; Dupont, DA; Fukuhara, LL; Mau, MK; Odom, SK; Perry, RU; Tokunaga, JS; Knowler, WC; Hoskin, MA; Andre, VL; Acton, KJ; Antone, S; Baptisto, NM; Bennett, PH; Bird, EC; Dacawyma, TS; Hanson, RL; Jackson, MC; Jay, PA; Kobus, KM; Roumain, J; Rowse, DH; Roy, RJ; Yazzie, M; Cooeyate, NJ; Chavez, M; Broussard, BA; Ghahate, JM; Hughte, G; Ingraham, LE; Kaskalla, RS; Kessler, D; Nashboo, Y; Poirier, S; Percy, CA; Barber, R; Benson, MB; Duncan, R; Glass, M; Gohdes, D; Grant, W; Horse, E; Morgan, T; Reidy, M; Bain, R; Bambad, J; Brenneman, T; Dunegan, C; Edelstein, SL; Grimes, KL; Jones, S; Jones, TL; Klepac, H; Lachin, JM; Mucik, P; Orlosky, R; Rochon, J; Stimpson, CE; Van Aerden, C; Eastman, R; Garfield, S; Harris, M; Andres, R; Engelgau, M; Narayan, V; Williamson, D; Herman, W; Chandler, WL; Marcovina, SM; McMillan, T; Rautaharju, PM; Rautaharju, FSR; Mayer-Davis, EJ; O'Leary, DH; Funk, LRC; O'Leary, KA; Scherzinger, AL; Stamm, ER; Gillis, BP; Kriska, AM; Huffmyer, C; Meier, A; Venditti, EM; Wing, RR; Haffner, SM; Ratner, RE; Olefsky, JM; Santiago, JV; Saudek, CD; Knowler, WC; Montez, MG; Fujimoto, WY; Hamman, RF; Nathan, DM
    The Diabetes Prevention Program - Design and methods for a clinical trial in the prevention of type 2 diabetes
    DIABETES CARE
    
    G.A. Bray et al., "The Diabetes Prevention Program - Design and methods for a clinical trial in the prevention of type 2 diabetes", DIABET CARE, 22(4), 1999, pp. 623-634
29. Albers, JJ; Pitman, W; Wolfbauer, G; Cheung, MC; Kennedy, H; Tu, AY; Marcovina, SM; Paigen, B
    Relationship between phospholipid transfer protein activity and HDL level and size among inbred mouse strains
    JOURNAL OF LIPID RESEARCH
    
    J.J. Albers et al., "Relationship between phospholipid transfer protein activity and HDL level and size among inbred mouse strains", J LIPID RES, 40(2), 1999, pp. 295-301
30. Periard, D; Telenti, A; Sudre, P; Cheseaux, JJ; Halfon, P; Reymond, MJ; Marcovina, SM; Glauser, MP; Nicod, P; Darioli, R; Mooser, V
    Atherogenic dyslipidemia in HIV-infected individuals treated with proteaseinhibitors
    CIRCULATION
    
    D. Periard et al., "Atherogenic dyslipidemia in HIV-infected individuals treated with proteaseinhibitors", CIRCULATION, 100(7), 1999, pp. 700-705
31. Marcovina, SM; Koschinsky, ML
    Lipoprotein(a) concentration and apolipoprotein(a) size - A synergistic role in advanced atherosclerosis?
    CIRCULATION
    
    S.M. Marcovina e M.L. Koschinsky, "Lipoprotein(a) concentration and apolipoprotein(a) size - A synergistic role in advanced atherosclerosis?", CIRCULATION, 100(11), 1999, pp. 1151-1153
32. RAND ML; SANGRAR W; HANCOCK MA; TAYLOR DM; MARCOVINA SM; PACKHAM MA; KOSCHINSKY ML
    APOLIPOPROTEIN(A) ENHANCES PLATELET RESPONSES TO THE THROMBIN RECEPTOR-ACTIVATING PEPTIDE SFLLRN
    Arteriosclerosis, thrombosis, and vascular biology
    
    M.L. Rand et al., "APOLIPOPROTEIN(A) ENHANCES PLATELET RESPONSES TO THE THROMBIN RECEPTOR-ACTIVATING PEPTIDE SFLLRN", Arteriosclerosis, thrombosis, and vascular biology, 18(9), 1998, pp. 1393-1399
33. Dangas, G; Mehran, R; Harpel, PC; Sharma, SK; Marcovina, SM; Dube, G; Ambrose, JA; Fallon, JT
    Lipoprotein(a) and inflammation in human coronary atheroma: Association with the severity of clinical presentation
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    G. Dangas et al., "Lipoprotein(a) and inflammation in human coronary atheroma: Association with the severity of clinical presentation", J AM COL C, 32(7), 1998, pp. 2035-2042
34. Rahman, M; Jia, ZC; Gabel, BR; Marcovina, SM; Koschinsky, ML
    Expression of apolipoprotein(a) kringle IV type 9 in Escherichia coli: demonstration of a specific interaction between kringle IV type 9 and apolipoproteinB-100
    PROTEIN ENGINEERING
    
    M. Rahman et al., "Expression of apolipoprotein(a) kringle IV type 9 in Escherichia coli: demonstration of a specific interaction between kringle IV type 9 and apolipoproteinB-100", PROTEIN ENG, 11(12), 1998, pp. 1249-1256
35. PURNELL JQ; HOKANSON JE; MARCOVINA SM; STEFFES MW; CLEARY PA; BRUNZELL JD
    EFFECT OF EXCESSIVE WEIGHT-GAIN WITH INTENSIVE THERAPY OF TYPE-1 DIABETES ON LIPID-LEVELS AND BLOOD-PRESSURE - RESULTS FROM THE DCCT
    JAMA, the journal of the American Medical Association
    
    J.Q. Purnell et al., "EFFECT OF EXCESSIVE WEIGHT-GAIN WITH INTENSIVE THERAPY OF TYPE-1 DIABETES ON LIPID-LEVELS AND BLOOD-PRESSURE - RESULTS FROM THE DCCT", JAMA, the journal of the American Medical Association, 280(2), 1998, pp. 140-146
36. ARGYROPOULOS G; JENKINS A; KLEIN RL; LYONS T; WAGENHORST B; STARMAND J; MARCOVINA SM; ALBERS JJ; PRITCHARD PH; GARVEY WT
    TRANSMISSION OF 2 NOVEL MUTATIONS IN A PEDIGREE WITH FAMILIAL LECITHIN-CHOLESTEROL ACYLTRANSFERASE DEFICIENCY - STRUCTURE-FUNCTION-RELATIONSHIPS AND STUDIES IN A COMPOUND HETEROZYGOUS PROBAND
    Journal of lipid research
    
    G. Argyropoulos et al., "TRANSMISSION OF 2 NOVEL MUTATIONS IN A PEDIGREE WITH FAMILIAL LECITHIN-CHOLESTEROL ACYLTRANSFERASE DEFICIENCY - STRUCTURE-FUNCTION-RELATIONSHIPS AND STUDIES IN A COMPOUND HETEROZYGOUS PROBAND", Journal of lipid research, 39(9), 1998, pp. 1870-1876
37. JUNGNER I; MARCOVINA SM; WALLDIUS G; HOLME I; KOLAR W; STEINER E
    APOLIPOPROTEIN-B AND A-I VALUES IN 147,576 SWEDISH MALES AND FEMALES,STANDARDIZED ACCORDING TO THE WORLD-HEALTH-ORGANIZATION INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY FIRST INTERNATIONAL REFERENCE MATERIALS
    Clinical chemistry
    
    I. Jungner et al., "APOLIPOPROTEIN-B AND A-I VALUES IN 147,576 SWEDISH MALES AND FEMALES,STANDARDIZED ACCORDING TO THE WORLD-HEALTH-ORGANIZATION INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY FIRST INTERNATIONAL REFERENCE MATERIALS", Clinical chemistry, 44(8), 1998, pp. 1641-1649
38. GRAZIANI MS; ZANOLLA L; RIGHETTI G; MARCHETTI C; MOCARELLI P; MARCOVINA SM
    PLASMA APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B IN SURVIVORS OF MYOCARDIAL-INFARCTION AND IN A CONTROL-GROUP
    Clinical chemistry
    
    M.S. Graziani et al., "PLASMA APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B IN SURVIVORS OF MYOCARDIAL-INFARCTION AND IN A CONTROL-GROUP", Clinical chemistry, 44(1), 1998, pp. 134-140
39. JUNGER I; MARCOVINA SM; WALLDIUS G; HOLME I; KOLAR W; STEINER S
    APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-1 VALUES IN 147,576 SWEDISH MALES AND FEMALES STANDARDIZED ACCORDING TO THE WHO-IFCC INTERNATIONAL REFERENCE MATERIAL
    Clinical chemistry
    
    I. Junger et al., "APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-1 VALUES IN 147,576 SWEDISH MALES AND FEMALES STANDARDIZED ACCORDING TO THE WHO-IFCC INTERNATIONAL REFERENCE MATERIAL", Clinical chemistry, 44, 1998, pp. 358-358
40. PURNELL JQ; HOKANSON JE; MARCOVINA SM; STEFFES MW; CLEARY PA; BRUNZELL JD
    BODY-WEIGHT AND LIPIDS ASSOCIATED WITH CAROTID WALL THICKENING IN IDDM FROM THE DCCT EDIC TRIAL/
    Circulation
    
    J.Q. Purnell et al., "BODY-WEIGHT AND LIPIDS ASSOCIATED WITH CAROTID WALL THICKENING IN IDDM FROM THE DCCT EDIC TRIAL/", Circulation, 98(17), 1998, pp. 4149-4149
41. EDWARDS KL; MARCOVINA SM; LEONETTI DL; MCKNIGHT B; FUJIMOTO WY; AUSTIN MA
    ASSOCIATION BETWEEN LIPOPROTEIN(A) (LP(A)) SIZE AND LOW-DENSITY-LIPOPROTEIN (LDL) PARTICLE DIAMETER (SIZE) IN JAPANESE-AMERICAN (JA)
    Circulation
    
    K.L. Edwards et al., "ASSOCIATION BETWEEN LIPOPROTEIN(A) (LP(A)) SIZE AND LOW-DENSITY-LIPOPROTEIN (LDL) PARTICLE DIAMETER (SIZE) IN JAPANESE-AMERICAN (JA)", Circulation, 97(8), 1998, pp. 25-25
42. ESPELAND MA; MARCOVINA SM; MILLER V; WOOD PD; WASILAUSKAS C; SHERWIN R; SCHROTT H; BUSH TL
    EFFECT OF POSTMENOPAUSAL HORMONE-THERAPY ON LIPOPROTEIN(A) CONCENTRATION
    Circulation
    
    M.A. Espeland et al., "EFFECT OF POSTMENOPAUSAL HORMONE-THERAPY ON LIPOPROTEIN(A) CONCENTRATION", Circulation, 97(10), 1998, pp. 979-986
43. Marcovina, SM; Koschinsky, ML
    Lipoprotein(a) as a risk factor for coronary artery disease
    AMERICAN JOURNAL OF CARDIOLOGY
    
    S.M. Marcovina e M.L. Koschinsky, "Lipoprotein(a) as a risk factor for coronary artery disease", AM J CARD, 82(12A), 1998, pp. 57U-66U
44. Guyton, JR; Capuzzi, DM; Kreisberg, RA; Sprecher, DL; Marcovina, SM; Kashyap, ML
    Advances in dyslipidemia: Discussion session II
    AMERICAN JOURNAL OF CARDIOLOGY
    
    J.R. Guyton et al., "Advances in dyslipidemia: Discussion session II", AM J CARD, 82(12A), 1998, pp. 85U-86U
45. OLIVEIRA HCF; MA LM; MILNE R; MARCOVINA SM; INAZU A; MABUCHI H; TALL AR
    CHOLESTERYL ESTER TRANSFER PROTEIN-ACTIVITY ENHANCES PLASMA CHOLESTERYL ESTER FORMATION - STUDIES IN CETP TRANSGENIC MICE AND HUMAN GENETICCETP DEFICIENCY
    Arteriosclerosis, thrombosis, and vascular biology
    
    H.C.F. Oliveira et al., "CHOLESTERYL ESTER TRANSFER PROTEIN-ACTIVITY ENHANCES PLASMA CHOLESTERYL ESTER FORMATION - STUDIES IN CETP TRANSGENIC MICE AND HUMAN GENETICCETP DEFICIENCY", Arteriosclerosis, thrombosis, and vascular biology, 17(6), 1997, pp. 1045-1052
46. WILD SH; FORTMANN SP; MARCOVINA SM
    A PROSPECTIVE CASE-CONTROL STUDY OF LIPOPROTEIN(A) LEVELS AND APO(A) SIZE AND RISK OF CORONARY HEART-DISEASE IN STANFORD 5-CITY PROJECT PARTICIPANTS (VOL 17, PG 239, 1997)
    Arteriosclerosis, thrombosis, and vascular biology
    
    S.H. Wild et al., "A PROSPECTIVE CASE-CONTROL STUDY OF LIPOPROTEIN(A) LEVELS AND APO(A) SIZE AND RISK OF CORONARY HEART-DISEASE IN STANFORD 5-CITY PROJECT PARTICIPANTS (VOL 17, PG 239, 1997)", Arteriosclerosis, thrombosis, and vascular biology, 17(5), 1997, pp. 1010-1010
47. WILD SH; FORTMANN SP; MARCOVINA SM
    A PROSPECTIVE CASE-CONTROL STUDY OF LIPOPROTEIN(A) LEVELS AND APO(A) SIZE AND RISK OF CORONARY HEART-DISEASE IN STANFORD 5-CITY PROJECT PARTICIPANTS
    Arteriosclerosis, thrombosis, and vascular biology
    
    S.H. Wild et al., "A PROSPECTIVE CASE-CONTROL STUDY OF LIPOPROTEIN(A) LEVELS AND APO(A) SIZE AND RISK OF CORONARY HEART-DISEASE IN STANFORD 5-CITY PROJECT PARTICIPANTS", Arteriosclerosis, thrombosis, and vascular biology, 17(2), 1997, pp. 239-245
48. KOSCHINSKY ML; MARCOVINA SM
    LIPOPROTEIN(A) - STRUCTURAL IMPLICATIONS FOR PATHOPHYSIOLOGY
    International journal of clinical & laboratory research
    
    M.L. Koschinsky e S.M. Marcovina, "LIPOPROTEIN(A) - STRUCTURAL IMPLICATIONS FOR PATHOPHYSIOLOGY", International journal of clinical & laboratory research, 27(1), 1997, pp. 14-23
49. ROTIMI CN; COOPER RS; MARCOVINA SM; MCGEE D; OWOAJE E; LADIPO M
    SERUM DISTRIBUTION OF LIPOPROTEIN(A) IN AFRICAN-AMERICANS AND NIGERIANS - POTENTIAL EVIDENCE FOR A GENOTYPE-ENVIRONMENTAL EFFECT
    Genetic epidemiology
    
    C.N. Rotimi et al., "SERUM DISTRIBUTION OF LIPOPROTEIN(A) IN AFRICAN-AMERICANS AND NIGERIANS - POTENTIAL EVIDENCE FOR A GENOTYPE-ENVIRONMENTAL EFFECT", Genetic epidemiology, 14(2), 1997, pp. 157-168
50. HARPEL PC; ZHANG X; MIGLIORINI M; CHANG TS; MARCOVINA SM
    A NEW CATABOLIC PATHWAY FOR THE ATHEROGENIC LIPOPROTEIN, LP(A) - MONONUCLEAR-CELLS AND NEUTROPHILS DEGRADE LP(A) INTO 2 DOMAINS REFLECTING THE PROTEINASE ACTIVITY OF HUMAN-LEUKOCYTE ELASTASE (HLE) AND CATHEPSIN-G (CG)
    Thrombosis and haemostasis
    
    P.C. Harpel et al., "A NEW CATABOLIC PATHWAY FOR THE ATHEROGENIC LIPOPROTEIN, LP(A) - MONONUCLEAR-CELLS AND NEUTROPHILS DEGRADE LP(A) INTO 2 DOMAINS REFLECTING THE PROTEINASE ACTIVITY OF HUMAN-LEUKOCYTE ELASTASE (HLE) AND CATHEPSIN-G (CG)", Thrombosis and haemostasis, 1997, pp. 2321-2321
51. NAMEKATA T; MOORE DE; SUZUKI K; MORI M; KNOPP RH; MARCOVINA SM; PERRIN EB; HUGHES DA; HATANO S; HAYASHI C
    BIOLOGICAL AND LIFE-STYLE FACTORS, AND LIPID AND LIPOPROTEIN LEVELS AMONG JAPANESE-AMERICANS IN SEATTLE AND JAPANESE MEN IN JAPAN
    International journal of epidemiology
    
    T. Namekata et al., "BIOLOGICAL AND LIFE-STYLE FACTORS, AND LIPID AND LIPOPROTEIN LEVELS AMONG JAPANESE-AMERICANS IN SEATTLE AND JAPANESE MEN IN JAPAN", International journal of epidemiology, 26(6), 1997, pp. 1203-1213
52. HOELDTKE RD; BRYNER KD; HORVATH GG; BYERLY MR; HOBBS GR; MARCOVINA SM; LERNMARK A
    ANTIBODIES TO GAD AND GLYCEMIC CONTROL IN RECENT-ONSET IDDM
    Diabetes care
    
    R.D. Hoeldtke et al., "ANTIBODIES TO GAD AND GLYCEMIC CONTROL IN RECENT-ONSET IDDM", Diabetes care, 20(12), 1997, pp. 1900-1903
53. YANG XP; INAZU A; HONJO A; KOIZUMI I; KAJINAMI K; KOIZUMI J; MARCOVINA SM; ALBERS JJ; MABUCHI H
    CATALYTICALLY INACTIVE LECITHIN - CHOLESTEROL ACYLTRANSFERASE (LCAT) CAUSED BY A GLY-30 TO SER MUTATION IN A FAMILY WITH LCAT DEFICIENCY
    Journal of lipid research
    
    X.P. Yang et al., "CATALYTICALLY INACTIVE LECITHIN - CHOLESTEROL ACYLTRANSFERASE (LCAT) CAUSED BY A GLY-30 TO SER MUTATION IN A FAMILY WITH LCAT DEFICIENCY", Journal of lipid research, 38(3), 1997, pp. 585-591
54. KULKARNI KR; MARCOVINA SM; KRAUSS RM; GARBER DW; GLASSCOCK AM; SEGREST JP
    QUANTIFICATION OF HDL2 AND HDL3 CHOLESTEROL BY THE VERTICAL AUTO PROFILE-II (VAP-II) METHODOLOGY
    Journal of lipid research
    
    K.R. Kulkarni et al., "QUANTIFICATION OF HDL2 AND HDL3 CHOLESTEROL BY THE VERTICAL AUTO PROFILE-II (VAP-II) METHODOLOGY", Journal of lipid research, 38(11), 1997, pp. 2353-2364
55. MCCORMICK SPA; NG JK; CHAM CM; TAYLOR S; MARCOVINA SM; SEGREST JP; HAMMER RE; YOUNG SG
    TRANSGENIC MICE EXPRESSING HUMAN APOB95 AND APOB97
    The Journal of biological chemistry
    
    S.P.A. Mccormick et al., "TRANSGENIC MICE EXPRESSING HUMAN APOB95 AND APOB97", The Journal of biological chemistry, 272(38), 1997, pp. 23616-23622
56. KOSCHINSKY ML; SANGRAR W; MARCOVINA SM; TAYLOR DM; PACKHAM MA; RAND ML
    RECOMBINANT APOLIPOPROTEIN(A) AND LIPOPROTEIN(A) ENHANCE PLATELET RESPONSES TO A THROMBIN RECEPTOR-ACTIVATING PEPTIDE
    Atherosclerosis
    
    M.L. Koschinsky et al., "RECOMBINANT APOLIPOPROTEIN(A) AND LIPOPROTEIN(A) ENHANCE PLATELET RESPONSES TO A THROMBIN RECEPTOR-ACTIVATING PEPTIDE", Atherosclerosis, 134(1-2), 1997, pp. 143-143
57. KOSCHINSKY ML; MARCOVINA SM; MAY LF; GABEL BR
    ANALYSIS OF THE MECHANISM OF LIPOPROTEIN(A) ASSEMBLY
    Clinical genetics
    
    M.L. Koschinsky et al., "ANALYSIS OF THE MECHANISM OF LIPOPROTEIN(A) ASSEMBLY", Clinical genetics, 52(5), 1997, pp. 338-346
58. MOOSER V; MARCOVINA SM; WANG JP; HOBBS HH
    HIGH PLASMA-LEVELS OF APO(A) FRAGMENTS IN CAUCASIANS AND AFRICAN-AMERICANS WITH END-STAGE RENAL-DISEASE - IMPLICATIONS FOR PLASMA LP(A) ASSAY
    Clinical genetics
    
    V. Mooser et al., "HIGH PLASMA-LEVELS OF APO(A) FRAGMENTS IN CAUCASIANS AND AFRICAN-AMERICANS WITH END-STAGE RENAL-DISEASE - IMPLICATIONS FOR PLASMA LP(A) ASSAY", Clinical genetics, 52(5), 1997, pp. 387-392
59. KLEIN HG; SUBBAIAH PV; BARES M; BITTLINGMAIER R; WANG KW; MARCOVINA SM; SEIDEL S
    STUDIES ON SUBSTRATE-SPECIFICITY OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) USING SITE-DIRECTED MUTAGENESIS AND IN-VITRO EXPRESSION
    Circulation
    
    H.G. Klein et al., "STUDIES ON SUBSTRATE-SPECIFICITY OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) USING SITE-DIRECTED MUTAGENESIS AND IN-VITRO EXPRESSION", Circulation, 96(8), 1997, pp. 1256-1256
60. MARCOVINA SM; KENNEDY H; BITTOLOBON G; GALLI C; CASIGLIA E; PUATO M; PAULETTO P
    FISH INTAKE, NOT ONLY POLYMORPHISM OF APO(A) GENE-EXPRESSION, ACCOUNTS FOR PLASMA LP(A) LEVELS IN BANTU FISHERMEN OF TANZANIA - THE LUGALAWA STUDY
    Circulation
    
    S.M. Marcovina et al., "FISH INTAKE, NOT ONLY POLYMORPHISM OF APO(A) GENE-EXPRESSION, ACCOUNTS FOR PLASMA LP(A) LEVELS IN BANTU FISHERMEN OF TANZANIA - THE LUGALAWA STUDY", Circulation, 96(8), 1997, pp. 2672-2672
61. RODRIGUEZ BL; BURCHFIEL CM; FUJIMOTO W; SHARP DS; GROVE J; MARCOVINA SM; ABBOTT R; CURB JD
    THE ASSOCIATIONS OF FASTING GLUCOSE, INSULIN AND C-PEPTIDE WITH 15-YEAR TOTAL MORTALITY - THE HONOLULU HEART PROGRAM
    Circulation
    
    B.L. Rodriguez et al., "THE ASSOCIATIONS OF FASTING GLUCOSE, INSULIN AND C-PEPTIDE WITH 15-YEAR TOTAL MORTALITY - THE HONOLULU HEART PROGRAM", Circulation, 96(8), 1997, pp. 3676-3676
62. FORTMANN SP; MARCOVINA SM
    LIPOPROTEIN(A), A CLINICALLY ELUSIVE LIPOPROTEIN PARTICLE
    Circulation
    
    S.P. Fortmann e S.M. Marcovina, "LIPOPROTEIN(A), A CLINICALLY ELUSIVE LIPOPROTEIN PARTICLE", Circulation, 95(2), 1997, pp. 295-296
63. SANGRAR W; GABEL BR; BOFFA MB; WALKER JB; HANCOCK MA; MARCOVINA SM; HORREVOETS AJG; NESHEIM ME; KOSCHINSKY ML
    THE SOLUTION-PHASE INTERACTION BETWEEN APOLIPOPROTEIN(A) AND PLASMINOGEN INHIBITS THE BINDING OF PLASMINOGEN TO A PLASMIN-MODIFIED FIBRINOGEN SURFACE
    Biochemistry
    
    W. Sangrar et al., "THE SOLUTION-PHASE INTERACTION BETWEEN APOLIPOPROTEIN(A) AND PLASMINOGEN INHIBITS THE BINDING OF PLASMINOGEN TO A PLASMIN-MODIFIED FIBRINOGEN SURFACE", Biochemistry, 36(34), 1997, pp. 10353-10363
64. MOOSER V; SCHEER D; MARCOVINA SM; WANG JP; GUERRA R; COHEN J; HOBBS HH
    THE APO(A) GENE IS THE MAJOR DETERMINANT OF VARIATION IN PLASMA LP(A)LEVELS IN AFRICAN-AMERICANS
    American journal of human genetics
    
    V. Mooser et al., "THE APO(A) GENE IS THE MAJOR DETERMINANT OF VARIATION IN PLASMA LP(A)LEVELS IN AFRICAN-AMERICANS", American journal of human genetics, 61(2), 1997, pp. 402-417
65. PUMELL JQ; HAKANSON JE; MARCOVINA SM; CLEARY PA; STEFFES MW; BRUNZELL JD
    WEIGHT-GAIN ACCOMPANYING INTENSIVE DIABETES THERAPY IN TYPE-I DIABETES IS ASSOCIATED WITH HIGHER LEVELS OF DENSE LDL CHOLESTEROL
    Journal of investigative medicine
    
    J.Q. Pumell et al., "WEIGHT-GAIN ACCOMPANYING INTENSIVE DIABETES THERAPY IN TYPE-I DIABETES IS ASSOCIATED WITH HIGHER LEVELS OF DENSE LDL CHOLESTEROL", Journal of investigative medicine, 44(1), 1996, pp. 180-180
66. OBRIEN KD; REICHENBACH DD; MARCOVINA SM; KUUSISTO J; ALPERS CE; OTTO CM
    APOLIPOPROTEIN-B, APOLIPOPROTEI(A), AND APOLIPOPROTEIN-E ACCUMULATE IN THE MORPHOLOGICALLY EARLY LESION OF DEGENERATIVE VALVULAR AORTIC-STENOSIS
    Arteriosclerosis, thrombosis, and vascular biology
    
    K.D. Obrien et al., "APOLIPOPROTEIN-B, APOLIPOPROTEI(A), AND APOLIPOPROTEIN-E ACCUMULATE IN THE MORPHOLOGICALLY EARLY LESION OF DEGENERATIVE VALVULAR AORTIC-STENOSIS", Arteriosclerosis, thrombosis, and vascular biology, 16(4), 1996, pp. 523-532
67. GABEL BR; MAY LF; MARCOVINA SM; KOSCHINSKY ML
    LIPOPROTEIN(A) ASSEMBLY - QUANTITATIVE ASSESSMENT OF THE ROLE OF APO(A) KRINGLE-IV TYPE-2-10 IN PARTICLE FORMATION
    Arteriosclerosis, thrombosis, and vascular biology
    
    B.R. Gabel et al., "LIPOPROTEIN(A) ASSEMBLY - QUANTITATIVE ASSESSMENT OF THE ROLE OF APO(A) KRINGLE-IV TYPE-2-10 IN PARTICLE FORMATION", Arteriosclerosis, thrombosis, and vascular biology, 16(12), 1996, pp. 1559-1567
68. VITALIANO PP; SCANLAN JM; KRENZ C; SCHWARTZ RS; MARCOVINA SM
    PSYCHOLOGICAL DISTRESS, CAREGIVING, AND METABOLIC VARIABLES
    The journals of gerontology. Series B, Psychological sciences and social sciences
    
    P.P. Vitaliano et al., "PSYCHOLOGICAL DISTRESS, CAREGIVING, AND METABOLIC VARIABLES", The journals of gerontology. Series B, Psychological sciences and social sciences, 51(5), 1996, pp. 290-299
69. BILD DE; JACOBS DR; LIU K; WILLIAMS OD; HILNER JE; PERKINS LL; MARCOVINA SM; HULLEY SB
    7 YEAR TRENDS IN PLASMA LOW-DENSITY-LIPOPROTEIN-CHOLESTEROL IN YOUNG-ADULTS - THE CARDIA STUDY
    Annals of epidemiology
    
    D.E. Bild et al., "7 YEAR TRENDS IN PLASMA LOW-DENSITY-LIPOPROTEIN-CHOLESTEROL IN YOUNG-ADULTS - THE CARDIA STUDY", Annals of epidemiology, 6(3), 1996, pp. 235-245
70. ALBERS JJ; TU AY; PAIGEN B; CHEN H; CHEUNG MC; MARCOVINA SM
    TRANSGENIC MICE EXPRESSING HUMAN PHOSPHOLIPID TRANSFER PROTEIN HAVE INCREASED HDL NON-HDL CHOLESTEROL RATIO
    International journal of clinical & laboratory research
    
    J.J. Albers et al., "TRANSGENIC MICE EXPRESSING HUMAN PHOSPHOLIPID TRANSFER PROTEIN HAVE INCREASED HDL NON-HDL CHOLESTEROL RATIO", International journal of clinical & laboratory research, 26(4), 1996, pp. 262-267
71. YUDKIN JS; MARCOVINA SM; FOYLE WJ; FERNANDEZ M
    LIPOPROTEIN(A) IS NOT ELEVATED IN NONDIABETIC MICROALBUMINURIC SUBJECTS - A LONGITUDINAL-STUDY OF LIPOPROTEIN(A) CONCENTRATIONS AND APOLIPOPROTEIN(A) SIZE ISOFORMS
    International journal of clinical & laboratory research
    
    J.S. Yudkin et al., "LIPOPROTEIN(A) IS NOT ELEVATED IN NONDIABETIC MICROALBUMINURIC SUBJECTS - A LONGITUDINAL-STUDY OF LIPOPROTEIN(A) CONCENTRATIONS AND APOLIPOPROTEIN(A) SIZE ISOFORMS", International journal of clinical & laboratory research, 26(1), 1996, pp. 43-50
72. MARCOVINA SM; LIPPI G; GUIDI G
    LIPOPROTEIN(A) IMMUNOASSAYS - COMPARISON OF A SEMIQUANTITATIVE LATEX METHOD AND 2 MONOCLONAL ENZYME IMMUNOASSAYS (VOL 25, PG 201, 1995)
    International journal of clinical & laboratory research
    
    S.M. Marcovina et al., "LIPOPROTEIN(A) IMMUNOASSAYS - COMPARISON OF A SEMIQUANTITATIVE LATEX METHOD AND 2 MONOCLONAL ENZYME IMMUNOASSAYS (VOL 25, PG 201, 1995)", International journal of clinical & laboratory research, 26(1), 1996, pp. 50-50
73. HOEG JM; SANTAMARINAFOJO S; BERARD AM; CORNHILL JF; HERDERICK EE; FELDMAN SH; HAUDENSCHILD CC; VAISMAN BL; HOYT RF; DEMOSKY SJ; KAUFFMAN RD; HAZEL CM; MARCOVINA SM; BREWER HB
    OVEREXPRESSION OF LECITHIN, CHOLESTEROL ACYLTRANSFERASE IN TRANSGENICRABBITS PREVENTS DIET-INDUCED ATHEROSCLEROSIS
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    J.M. Hoeg et al., "OVEREXPRESSION OF LECITHIN, CHOLESTEROL ACYLTRANSFERASE IN TRANSGENICRABBITS PREVENTS DIET-INDUCED ATHEROSCLEROSIS", Proceedings of the National Academy of Sciences of the United Statesof America, 93(21), 1996, pp. 11448-11453
74. MARCOVINA SM; ALBERS JJ; WIJSMAN E; ZHANG ZH; CHAPMAN NH; KENNEDY H
    DIFFERENCES IN LP[A] CONCENTRATIONS AND APO[A] POLYMORPHS BETWEEN BLACK-AND-WHITE AMERICANS
    Journal of lipid research
    
    S.M. Marcovina et al., "DIFFERENCES IN LP[A] CONCENTRATIONS AND APO[A] POLYMORPHS BETWEEN BLACK-AND-WHITE AMERICANS", Journal of lipid research, 37(12), 1996, pp. 2569-2585
75. ALBERS JJ; KENNEDY H; MARCOVINA SM
    EVIDENCE THAT LP[A] CONTAINS ONE MOLECULE OF APO[A] AND ONE MOLECULE OF APO-B - EVALUATION OF AMINO-ACID-ANALYSIS DATA
    Journal of lipid research
    
    J.J. Albers et al., "EVIDENCE THAT LP[A] CONTAINS ONE MOLECULE OF APO[A] AND ONE MOLECULE OF APO-B - EVALUATION OF AMINO-ACID-ANALYSIS DATA", Journal of lipid research, 37(1), 1996, pp. 192-196
76. MOOSER V; MARCOVINA SM; WHITE AL; HOBBS HH
    KRINGLE-CONTAINING FRAGMENTS OF APOLIPOPROTEIN(A) CIRCULATE IN HUMAN PLASMA AND ARE EXCRETED INTO THE URINE
    The Journal of clinical investigation
    
    V. Mooser et al., "KRINGLE-CONTAINING FRAGMENTS OF APOLIPOPROTEIN(A) CIRCULATE IN HUMAN PLASMA AND ARE EXCRETED INTO THE URINE", The Journal of clinical investigation, 98(10), 1996, pp. 2414-2424
77. MARCOVINA SM; LIPPI G; BAGATELL CJ; BREMNER WJ
    TESTOSTERONE-INDUCED SUPPRESSION OF LIPOPROTEIN(A) IN NORMAL MEN - RELATION TO BASAL LIPOPROTEIN(A) LEVEL
    Atherosclerosis
    
    S.M. Marcovina et al., "TESTOSTERONE-INDUCED SUPPRESSION OF LIPOPROTEIN(A) IN NORMAL MEN - RELATION TO BASAL LIPOPROTEIN(A) LEVEL", Atherosclerosis, 122(1), 1996, pp. 89-95
78. PURNELL JQ; HOKANSON JE; MARCOVINA SM; CLEARY PA; STEFFES MW; BRUNZELL JD
    DYSLIPIDEMIA OF WEIGHT-GAIN ACCOMPANYING INTENSIVE DIABETES THERAPY IN TYPE-I DIABETES-MELLITUS
    Diabetes
    
    J.Q. Purnell et al., "DYSLIPIDEMIA OF WEIGHT-GAIN ACCOMPANYING INTENSIVE DIABETES THERAPY IN TYPE-I DIABETES-MELLITUS", Diabetes, 45, 1996, pp. 130-130
79. MARCOVINA SM; HOBBS HH; ALBERS JJ
    RELATION BETWEEN NUMBER OF APOLIPOPROTEIN(A) KRINGLE-4 REPEATS AND MOBILITY OF ISOFORMS IN AGAROSE-GEL - BASIS FOR A STANDARDIZED ISOFORM NOMENCLATURE
    Clinical chemistry
    
    S.M. Marcovina et al., "RELATION BETWEEN NUMBER OF APOLIPOPROTEIN(A) KRINGLE-4 REPEATS AND MOBILITY OF ISOFORMS IN AGAROSE-GEL - BASIS FOR A STANDARDIZED ISOFORM NOMENCLATURE", Clinical chemistry, 42(3), 1996, pp. 436-439
80. AVERNA M; MARCOVINA SM; NOTO D; COLE TG; KRUL ES; SCHONFELD G
    FAMILIAL HYPOBETALIPOPROTEINEMIA IS NOT ASSOCIATED WITH LOW-LEVELS OFLIPOPROTEIN(A)
    Arteriosclerosis, thrombosis, and vascular biology
    
    M. Averna et al., "FAMILIAL HYPOBETALIPOPROTEINEMIA IS NOT ASSOCIATED WITH LOW-LEVELS OFLIPOPROTEIN(A)", Arteriosclerosis, thrombosis, and vascular biology, 15(12), 1995, pp. 2165-2175
81. MARCOVINA SM; LIPPI G; GUIDI G
    LIPOPROTEIN(A) IMMUNOASSAYS - COMPARISON OF A SEMIQUANTITATIVE LATEX METHOD AND 2 MONOCLONAL ENZYME IMMUNOASSAYS
    International journal of clinical & laboratory research
    
    S.M. Marcovina et al., "LIPOPROTEIN(A) IMMUNOASSAYS - COMPARISON OF A SEMIQUANTITATIVE LATEX METHOD AND 2 MONOCLONAL ENZYME IMMUNOASSAYS", International journal of clinical & laboratory research, 25(4), 1995, pp. 201-204
82. MAHER VMG; BROWN BG; MARCOVINA SM; HILLGER LA; ZHAO XQ; ALBERS JJ
    EFFECTS OF LOWERING ELEVATED LDL CHOLESTEROL ON THE CARDIOVASCULAR RISK OF LIPOPROTEIN(A)
    JAMA, the journal of the American Medical Association
    
    V.M.G. Maher et al., "EFFECTS OF LOWERING ELEVATED LDL CHOLESTEROL ON THE CARDIOVASCULAR RISK OF LIPOPROTEIN(A)", JAMA, the journal of the American Medical Association, 274(22), 1995, pp. 1771-1774
83. MORIYAMA K; SASAKI J; ARAKAWA F; TAKAMI N; MAEDA E; MATSUNAGA A; TAKADA Y; MIDORIKAWA K; YANASE T; YOSHINO G; MARCOVINA SM; ALBERS JJ; ARAKAWA K
    2 NOVEL POINT MUTATIONS IN THE LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) GENE RESULTING IN LCAT DEFICIENCY - LCAT (G(873) DELETION) AND LCAT (GLY(344)-]SER)
    Journal of lipid research
    
    K. Moriyama et al., "2 NOVEL POINT MUTATIONS IN THE LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) GENE RESULTING IN LCAT DEFICIENCY - LCAT (G(873) DELETION) AND LCAT (GLY(344)-]SER)", Journal of lipid research, 36(11), 1995, pp. 2329-2343
84. KUIVENHOVEN JA; VOORST EJGMVT; WIEBUSCH H; MARCOVINA SM; FUNKE H; ASSMANN G; PRITCHARD PH; KASTELEIN JJP; HILL J; ADLER L; ERRRAMI A
    A UNIQUE GENETIC AND BIOCHEMICAL PRESENTATION OF FISH-EYE DISEASE
    The Journal of clinical investigation
    
    J.A. Kuivenhoven et al., "A UNIQUE GENETIC AND BIOCHEMICAL PRESENTATION OF FISH-EYE DISEASE", The Journal of clinical investigation, 96(6), 1995, pp. 2783-2791
85. VAISMAN BL; KLEIN HG; ROUIS M; BERARD AM; KINDT MR; TALLEY GD; MEYN SM; HOYT RF; MARCOVINA SM; ALBERS JJ; HOEG JM; BREWER HB; SANTAMARINAFOJO S
    OVEREXPRESSION OF HUMAN LECITHIN-CHOLESTEROL ACYLTRANSFERASE LEADS TOHYPERALPHALIPOPROTEINEMIA IN TRANSGENIC MICE
    The Journal of biological chemistry
    
    B.L. Vaisman et al., "OVEREXPRESSION OF HUMAN LECITHIN-CHOLESTEROL ACYLTRANSFERASE LEADS TOHYPERALPHALIPOPROTEINEMIA IN TRANSGENIC MICE", The Journal of biological chemistry, 270(20), 1995, pp. 12269-12275
86. PURNELL JQ; MARCOVINA SM; HOKANSON JE; KENNEDY H; CLEARY PA; STEFFES MW; BRUNZELL JD
    LEVELS OF LIPOPROTEIN(A), APOLIPOPROTEIN-B, AND LIPOPROTEIN CHOLESTEROL DISTRIBUTION IN IDDM - RESULTS FROM FOLLOW-UP IN THE DIABETES CONTROL AND COMPLICATIONS TRIAL
    Diabetes
    
    J.Q. Purnell et al., "LEVELS OF LIPOPROTEIN(A), APOLIPOPROTEIN-B, AND LIPOPROTEIN CHOLESTEROL DISTRIBUTION IN IDDM - RESULTS FROM FOLLOW-UP IN THE DIABETES CONTROL AND COMPLICATIONS TRIAL", Diabetes, 44(10), 1995, pp. 1218-1226
87. LEVINE DM; MARCOVINA SM
    THE EFFECT OF APO(A) ISOFORM SIZE ON LP(A) MEASUREMENT BY A COMMERCIAL ASSAY
    Clinical chemistry
    
    D.M. Levine e S.M. Marcovina, "THE EFFECT OF APO(A) ISOFORM SIZE ON LP(A) MEASUREMENT BY A COMMERCIAL ASSAY", Clinical chemistry, 41(6), 1995, pp. 139-139
88. MARCOVINA SM; ALBERS JJ; GABEL B; KOSCHINSKY ML; GAUR VP
    EFFECT OF THE NUMBER OF APOLIPOPROTEIN(A) KRINGLE-4 DOMAINS ON IMMUNOCHEMICAL MEASUREMENTS OF LIPOPROTEIN(A)
    Clinical chemistry
    
    S.M. Marcovina et al., "EFFECT OF THE NUMBER OF APOLIPOPROTEIN(A) KRINGLE-4 DOMAINS ON IMMUNOCHEMICAL MEASUREMENTS OF LIPOPROTEIN(A)", Clinical chemistry, 41(2), 1995, pp. 246-255
89. HARPEL PC; ZHANG X; MARCOVINA SM
    HUMAN-LEUKOCYTE ELASTASE (HLE) DEGRADES LIPOPROTEIN(A) INTO LOWER MOLECULAR-WEIGHT FRAGMENTS THAT RETAIN FIBRIN BINDING-ACTIVITY AND HAVE ENHANCED TISSUE FACTOR STIMULATING ACTIVITY
    Blood
    
    P.C. Harpel et al., "HUMAN-LEUKOCYTE ELASTASE (HLE) DEGRADES LIPOPROTEIN(A) INTO LOWER MOLECULAR-WEIGHT FRAGMENTS THAT RETAIN FIBRIN BINDING-ACTIVITY AND HAVE ENHANCED TISSUE FACTOR STIMULATING ACTIVITY", Blood, 86(10), 1995, pp. 785-785
90. MAHER VMG; BROWN BG; ZHAO XQ; CHEUNG M; MARCOVINA SM; ALBERS JJ
    CONTRASTING EFFECTS OF APOPROTEINS A-I AND A-II ON CORONARY-ARTERY DISEASE CHANGE IN MEN DURING 2.5 YEARS IN LIPID-LOWERING THERAPY
    Journal of the American College of Cardiology
    
    V.M.G. Maher et al., "CONTRASTING EFFECTS OF APOPROTEINS A-I AND A-II ON CORONARY-ARTERY DISEASE CHANGE IN MEN DURING 2.5 YEARS IN LIPID-LOWERING THERAPY", Journal of the American College of Cardiology, 1994, pp. 10000100-10000100
91. SANGRAR W; MARCOVINA SM; KOSCHINSKY ML
    EXPRESSION AND CHARACTERIZATION OF APOLIPOPROTEIN(A) KRINGLE-IV TYPE-1, TYPE-2 AND TYPE-10 IN MAMMALIAN-CELLS
    Protein engineering
    
    W. Sangrar et al., "EXPRESSION AND CHARACTERIZATION OF APOLIPOPROTEIN(A) KRINGLE-IV TYPE-1, TYPE-2 AND TYPE-10 IN MAMMALIAN-CELLS", Protein engineering, 7(5), 1994, pp. 723-731
92. KULKARNI KR; GARBER DW; MARCOVINA SM; SEGREST JP
    QUANTIFICATION OF CHOLESTEROL IN ALL LIPOPROTEIN CLASSES BY THE VAP-II METHOD
    Journal of lipid research
    
    K.R. Kulkarni et al., "QUANTIFICATION OF CHOLESTEROL IN ALL LIPOPROTEIN CLASSES BY THE VAP-II METHOD", Journal of lipid research, 35(1), 1994, pp. 159-168
93. DAY JR; ALBERS JJ; LOFTONDAY CE; GILBERT TL; CHING AFT; GRANT FJ; OHARA PJ; MARCOVINA SM; ADOLPHSON JL
    COMPLETE CDNA-ENCODING HUMAN PHOSPHOLIPID TRANSFER PROTEIN FROM HUMANENDOTHELIAL COILS
    The Journal of biological chemistry
    
    J.R. Day et al., "COMPLETE CDNA-ENCODING HUMAN PHOSPHOLIPID TRANSFER PROTEIN FROM HUMANENDOTHELIAL COILS", The Journal of biological chemistry, 269(12), 1994, pp. 9388-9391
94. MEI JV; POWELL MK; HENDERSON LO; SMITH SJ; COOPER GR; MARCOVINA SM; HANNON WH
    METHOD-DEPENDENT VARIATIONS IN THE STABILITY OF APOLIPOPROTEIN-B IN ASTABILIZED LIQUID REFERENCE MATERIAL
    Clinical chemistry
    
    J.V. Mei et al., "METHOD-DEPENDENT VARIATIONS IN THE STABILITY OF APOLIPOPROTEIN-B IN ASTABILIZED LIQUID REFERENCE MATERIAL", Clinical chemistry, 40(5), 1994, pp. 716-722
95. MARCOVINA SM; GAUR VP; ALBERS JJ
    BIOLOGICAL VARIABILITY OF CHOLESTEROL, TRIGLYCERIDE, LOW-DENSITY AND HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL, LIPOPROTEIN(A), AND APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B
    Clinical chemistry
    
    S.M. Marcovina et al., "BIOLOGICAL VARIABILITY OF CHOLESTEROL, TRIGLYCERIDE, LOW-DENSITY AND HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL, LIPOPROTEIN(A), AND APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B", Clinical chemistry, 40(4), 1994, pp. 574-578
96. MARCOVINA SM; ALBERS JJ; KENNEDY H; MEI JV; HENDERSON LO; HANNON WH
    INTERNATIONAL FEDERATION OF CLINICAL-CHEMISTRY STANDARDIZATION PROJECT FOR MEASUREMENTS OF APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B .4. COMPARABILITY OF APOLIPOPROTEIN-B VALUES BY USE OF INTERNATIONAL REFERENCEMATERIAL
    Clinical chemistry
    
    S.M. Marcovina et al., "INTERNATIONAL FEDERATION OF CLINICAL-CHEMISTRY STANDARDIZATION PROJECT FOR MEASUREMENTS OF APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B .4. COMPARABILITY OF APOLIPOPROTEIN-B VALUES BY USE OF INTERNATIONAL REFERENCEMATERIAL", Clinical chemistry, 40(4), 1994, pp. 586-592
97. BACHORIK PS; LOVEJOY KL; CARROLL MD; JOHNSON CL; ALBERS JJ; MARCOVINA SM
    MEASUREMENT OF APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B DURING THE NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES)-III
    Clinical chemistry
    
    P.S. Bachorik et al., "MEASUREMENT OF APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B DURING THE NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES)-III", Clinical chemistry, 40(10), 1994, pp. 1915-1920
98. ALBERS JJ; MARCOVINA SM
    STANDARDIZATION OF LP(A) MEASUREMENTS
    Chemistry and physics of lipids
    
    J.J. Albers e S.M. Marcovina, "STANDARDIZATION OF LP(A) MEASUREMENTS", Chemistry and physics of lipids, 67-8, 1994, pp. 257-263
99. MARCOVINA SM; ALBERS JJ; HENDERSON LO; HANNON WH
    INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY STANDARDIZATION PROJECT FOR MEASUREMENTS OF APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B .3. COMPARABILITY OF APOLIPOPROTEIN-A-I VALUES BY USE OF INTERNATIONAL REFERENCE MATERIAL
    Clinical chemistry
    
    S.M. Marcovina et al., "INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY STANDARDIZATION PROJECT FOR MEASUREMENTS OF APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B .3. COMPARABILITY OF APOLIPOPROTEIN-A-I VALUES BY USE OF INTERNATIONAL REFERENCE MATERIAL", Clinical chemistry, 39(5), 1993, pp. 773-781
100. MARCOVINA SM
     STANDARDIZATION OF APOLIPOPROTEIN ASSAYS - THE IFCC CONTRIBUTION
     Annales de biologie clinique
     
     S.M. Marcovina, "STANDARDIZATION OF APOLIPOPROTEIN ASSAYS - THE IFCC CONTRIBUTION", Annales de biologie clinique, 51(3-5), 1993, pp. 362-362